We are live on
!
Find out more
JE
JMAC Enterprises Portfolio holdings
AUM
$522M
1-Year Est. Return
15.34%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
+15.34%
3 Year Est. Return
+52.85%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$364M
AUM Growth
+$7.42M
(+2.1%)
Cap. Flow
-$21.6M
Cap. Flow
% of AUM
-5.94%
Top 10 Holdings %
Top 10 Hldgs %
37.94%
Holding
180
New
8
Increased
28
Reduced
112
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blackrock
BLK
|
+$244K |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$219K |
| 3 |
Air Products & Chemicals
APD
|
+$217K |
| 4 |
iShares US Healthcare ETF
IYH
|
+$217K |
| 5 |
DuPont de Nemours
DD
|
+$211K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.56M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.38M |
| 3 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$881K |
| 4 |
Invesco CurrencyShares Australian Dollar Trust
FXA
|
+$843K |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$801K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 10.67% |
| 2 | Technology | 4.79% |
| 3 | Consumer Staples | 3.26% |
| 4 | Financials | 2.07% |
| 5 | Consumer Discretionary | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Blackrock
BLK
$165B
| $259K | 0.07% |
+365
| New | +$244K |
|
152
Mondelez International
MDLZ
$77.1B
| $255K | 0.07% |
3,831
-3
| -0.1% | -$190 |
|
153
Intel
INTC
$491B
| $243K | 0.07% |
9,192
-800
| -8% | -$22.2K |
|
154
CMS Energy
CMS
$22.7B
| $240K | 0.07% |
3,792
| – | – |
|
155
Applied Materials
AMAT
$421B
| $240K | 0.07% |
2,461
-5
| -0.2% | -$480 |
|
156
Citigroup
C
$218B
| $236K | 0.06% |
5,211
-2,610
| -33% | -$119K |
|
157
Ferrari
RACE
$65.8B
| $235K | 0.06% |
1,097
-69
| -6% | -$14.2K |
|
|
158
DuPont de Nemours
DD
$18.4B
| $228K | 0.06% |
+2,647
| New | +$211K |
|
159
ASML
ASML
$668B
| $227K | 0.06% |
415
-194
| -32% | -$102K |
|
|
160
Vanguard FTSE Emerging Markets ETF
VWO
$119B
| $224K | 0.06% |
+5,745
| New | +$219K |
|
161
iShares Biotechnology ETF
IBB
$9.32B
| $224K | 0.06% |
1,703
-3
| -0.2% | -$388 |
|
162
TSMC
TSM
$2.09T
| $224K | 0.06% |
3,001
| – | – |
|
|
163
iShares US Healthcare ETF
IYH
$3.06B
| $223K | 0.06% |
+3,930
| New | +$217K |
|
164
Alcon
ALC
$34.1B
| $217K | 0.06% |
+3,163
| New | +$202K |
|
165
Hershey
HSY
$34.5B
| $216K | 0.06% |
931
| – | – |
|
166
NextEra Energy
NEE
$185B
| $206K | 0.06% |
+2,470
| New | +$200K |
|
|
WBA
167
DELISTED
Walgreens Boots Alliance
WBA
| $205K | 0.06% |
5,500
-8,100
| -60% | -$305K |
|
168
Prologis
PLD
$137B
| $203K | 0.06% |
+1,803
| New | +$200K |
|
169
ResMed
RMD
$28.6B
| $202K | 0.06% |
971
| – | – |
|
170
Oracle
ORCL
$350B
| $200K | 0.06% |
+2,451
| New | +$186K |
|
171
Ford
F
$56.4B
| $187K | 0.05% |
16,118
+244
| +2% | +$3.13K |
|
172
Eledon Pharmaceuticals
ELDN
$309M
| $124K | 0.03% |
54,538
| – | – |
|
|
BCLI
173
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $66.3K | 0.02% |
2,695
| – | – |
|
174
Moleculin Biotech
MBRX
$14.9M
| $13.9K | ﹤0.01% |
35
| – | – |
|
175
Crown Castle
CCI
$34.4B
| – | – |
-2,500
| Closed | -$361K |
|
Similar funds
LT
SC
TCM
GS
WFA
SCM
SW
ETS
JMAC Enterprises's Q4 2022 Portfolio in Review
As of Q4 2022, JMAC Enterprises held 180 positions worth $364M, up 2.1% from $356M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
JMAC Enterprises withdrew a net $21.6M in Q4 2022, closing 6 positions and reducing 112 holdings. Its most notable exit was Gilead Sciences, an estimated $620K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 9.7% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, JMAC Enterprises opened a new position in Blackrock worth $259K.
- JMAC Enterprises's largest Q4 2022 buy was Blackrock: 365 shares worth $259K.
- JMAC Enterprises added most to Air Products & Chemicals in Q4 2022, an estimated $217K increase.
- JMAC Enterprises's biggest Q4 2022 reduction was State Street Materials Select Sector SPDR ETF, cutting an estimated $1.56M.
- JMAC Enterprises fully exited Gilead Sciences in Q4 2022, selling an estimated $620K.
- JMAC Enterprises's ten largest holdings make up 38% of its $364M portfolio in Q4 2022.
- JMAC Enterprises opened 8 new positions and closed 6 in Q4 2022.
- JMAC Enterprises's portfolio value rose 2.1% quarter-over-quarter to $364M.
Based on JMAC Enterprises's 13F filing for Q4 2022, filed 23 Jan 2023.